These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7213342)

  • 1. The covalent nature of the human antithrombin III--thrombin bond.
    Longas MO; Finlay TH
    Biochem J; 1980 Sep; 189(3):481-9. PubMed ID: 7213342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissociation of complexes and their derivatives formed during inhibition of bovine thrombin and activated factor X by antithrombin III.
    Jesty J
    J Biol Chem; 1979 Feb; 254(4):1044-9. PubMed ID: 762113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The N-terminal domain of antithrombin-III is essential for heparin binding and complex-formation with, but not cleavage by, alpha-thrombin.
    Austin RC; Sheffield WP; Rachubinski RA; Blajchman MA
    Biochem J; 1992 Mar; 282 ( Pt 2)(Pt 2):345-51. PubMed ID: 1546950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routes of thrombin action in the production of proteolytically modified, secondary forms of antithrombin-thrombin complex.
    Fish WW; Orre K; Björk I
    Eur J Biochem; 1979 Nov; 101(1):39-44. PubMed ID: 510313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation and stability of the complex formed between human antithrombin-III and thrombin.
    Ferguson WS; Finlay TH
    Arch Biochem Biophys; 1983 Jan; 220(1):301-8. PubMed ID: 6338832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of thrombin-antithrombin III complex with vitronectin in serum.
    Ill CR; Ruoslahti E
    J Biol Chem; 1985 Dec; 260(29):15610-5. PubMed ID: 2415521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for an ester bond between thrombin and heparin cofactor.
    Owen WG; Penick GD; Yoder E; Poole BL
    Thromb Haemost; 1976 Feb; 35(1):87-95. PubMed ID: 60792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation, characterization and detection of a ternary complex between S protein, thrombin and antithrombin III in serum.
    Preissner KT; Zwicker L; Müller-Berghaus G
    Biochem J; 1987 Apr; 243(1):105-11. PubMed ID: 3606566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Properties of antithrombin-thrombin complex formed in the presence and in the absence of heparin.
    Danielsson A; Björk I
    Biochem J; 1983 Aug; 213(2):345-53. PubMed ID: 6615439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a pentosan polysulphate upon thrombin and factor Xa inactivation by antithrombin III.
    Scully MF; Kakkar VV
    Biochem J; 1984 Sep; 222(3):571-8. PubMed ID: 6207810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and characterization of rat plasma antithrombin III.
    Takahara H; Sinohara H
    Biochim Biophys Acta; 1980 Mar; 612(1):185-94. PubMed ID: 7362830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombin Glasgow II: alanine 382 to threonine mutation in the serpin P12 position, resulting in a substrate reaction with thrombin.
    Ireland H; Lane DA; Thompson E; Walker ID; Blench I; Morris HR; Freyssinet JM; Grunebaum L; Olds R; Thein SL
    Br J Haematol; 1991 Sep; 79(1):70-4. PubMed ID: 1911389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin and ionic strength-dependent conversion of antithrombin III from an inhibitor to a substrate of alpha-thrombin.
    Olson ST
    J Biol Chem; 1985 Aug; 260(18):10153-60. PubMed ID: 4019506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociation of antithrombin III--thrombin complex. Formation of active and inactive antithrombin III.
    Griffith MJ; Lundblad RL
    Biochemistry; 1981 Jan; 20(1):105-10. PubMed ID: 7470462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression in a cell-free system of normal and variant forms of human antithrombin III. Ability to bind heparin and react with alpha-thrombin.
    Austin RC; Rachubinski RA; Fernandez-Rachubinski F; Blajchman MA
    Blood; 1990 Oct; 76(8):1521-9. PubMed ID: 2207328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A coagulation pathway on bovine aortic segments leading to generation of Factor Xa and thrombin.
    Stern DM; Nawroth PP; Kisiel W; Handley D; Drillings M; Bartos J
    J Clin Invest; 1984 Dec; 74(6):1910-21. PubMed ID: 6439737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of inactivation of trypsin by antithrombin.
    Danielsson A; Björk I
    Biochem J; 1982 Oct; 207(1):21-8. PubMed ID: 6817749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The electrophoretically 'slow' and 'fast' forms of the alpha 2-macroglobulin molecule.
    Barrett AJ; Brown MA; Sayers CA
    Biochem J; 1979 Aug; 181(2):401-18. PubMed ID: 91367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
    Jørgensen M; Petersen LC; Thorsen S
    J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombin Vicenza, Ala 384 to Pro (GCA to CCA) mutation, transforming the inhibitor into a substrate.
    Caso R; Lane DA; Thompson EA; Olds RJ; Thein SL; Panico M; Blench I; Morris HR; Freyssinet JM; Aiach M
    Br J Haematol; 1991 Jan; 77(1):87-92. PubMed ID: 1998601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.